CVS Health (CVS) Tops Q4 EPS by 19c, Beats on Revenue; Offers FY25 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads gains as SpaceX, Super Micro results improve AI appetite
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
- Abbott plans to spin off its nutrition unit as a standalone public company
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Alphabet shares drop ahead of earnings next week
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Flutter Entertainment to cut up to 1,400 jobs amid UK tax increases
CVS HEALTH CORPORATION REPORTS FOURTH QUARTER AND FULL-YEAR 2024 RESULTS
February 12, 2025 6:30 AM ESTFourth Quarter Highlights
Total revenues increased to $97.7 billion, up 4.2% compared to prior yearGAAP diluted EPS of $1.30 and Adjusted EPS of $1.19Full-Year Highlights
Total revenues increased to $372.8 billion, up 4.2% compared to prior yearGAAP diluted EPS of $3.66 and Adjusted EPS of $5.42Generated cash flow from operations of $9.1 billion2025 Full-Year Guidance
GAAP diluted EPS guidance range of $4.58 to... More


